ICD-9
QUICK REFERENCE TO 2015 ICD-9-CM DIAGNOSIS CODES FOR COMMON CANCERS
DISCLAIMER
Note: These codes are valid for billings to Medicare Administrative Contractors (MACs)
for dates of service on or after October 1, 2013. Pending the adoption of ICD-10 on
October 1, 2015, ICD-9 codes can only be used for dates of service on or before
September 30, 2015.
In the absence of written notifications or bulletins from other payers, we recommend that
you verify which version of ICD-9-CM to use for claims with each one of your other payers.
Bladder
188.x
188.0
188.1
188.2
188.3
188.4
188.5
188.6
188.7
188.8
188.9
Malignant neoplasm of bladder
Trigone of urinary bladder
Dome of urinary bladder
Lateral wall of urinary bladder
Anterior wall of urinary bladder
Posterior wall of urinary bladder
Bladder neck
Ureteric orifice
Urachus
Other specified sites of bladder
Bladder, part unspecified
Bone
170.x
170.0
170.1
170.2
170.3
170.4
170.5
170.6
170.7
170.8
170.9
Malignant neoplasm of bone and articular
cartilage
Bones of skull and face, except mandible
Mandible
Vertebral column, excluding sacrum and coccyx
Ribs, sternum, and clavicle
Scapula and long bones of upper limb
Short bones of upper limb
Pelvic bones, sacrum, and coccyx
Long bones of lower limb
Short bones of lower limb
Bone and articular cartilage site unspecified
Brain
191.x
191.0
191.1
191.2
191.3
191.4
191.5
191.6
191.7
191.8
191.9
Malignant neoplasm of female breast
Nipple and areola
Central portion
Upper-inner quadrant
Lower-inner quadrant
Upper-outer quadrant
Lower-outer quadrant
Axillary tail
Other specified sites of female breast
Breast (female), unspecified
Malignant neoplasm of male breast
Nipple and areola
Other and unspecified sites of male breast
Malignant neoplasm of cervix uteri
Endocervix
Exocervix
Other specified sites of cervix
Cervix uteri, unspecified
Colon & Rectum
153.x
153.0
153.1
153.2
Sigmoid colon
Cecum
Appendix
Ascending colon
Splenic flexure
Other specified sites of large intestine
Colon, unspecified
Malignant neoplasm of rectum,
rectosigmoid junction and anus
Rectosigmoid junction
Rectum
Anal canal
Anus, unspecified
Other
Endocrine Glands
193
194.x
194.0
194.1
194.3
194.4
194.5
194.6
194.8
194.9
150.x
150.0
150.1
150.2
150.3
150.4
150.5
150.8
150.9
Malignant neoplasm of thyroid gland
Malignant neoplasm of other endocrine
glands and related structures
Adrenal gland
Parathyroid gland
Pituitary gland and craniopharyngeal duct
Pineal gland
Carotid body
Aortic body and other paraganglia
Other
Endocrine gland, site unspecified
Malignant neoplasm of colon
Hepatic flexure
Transverse colon
Descending colon
Malignant neoplasm of esophagus
Cervical esophagus
Thoracic esophagus
Abdominal esophagus
Upper third of esophagus
Middle third of esophagus
Lower third of esophagus
Other specified part
Esophagus, unspecified
Intestine
152.x
Cervix
180.x
180.0
180.1
180.8
180.9
154.0
154.1
154.2
154.3
154.8
The codes included in this compilation were independently selected by The Lash Group
and are not intended to encourage or suggest a use of PROCRIT® (epoetin alfa) that is
inconsistent with the FDA approved full Prescribing Information, including Boxed
WARNING, for PROCRIT®.
Esophagus
Malignant neoplasm of brain
Cerebrum, except lobes and ventricles
Frontal lobe
Temporal lobe
Parietal lobe
Occipital lobe
Ventricles
Cerebellum NOS
Brain stem
Other parts of brain
Brain, unspecified
Breast
174.x
174.0
174.1
174.2
174.3
174.4
174.5
174.6
174.8
174.9
175.x
175.0
175.9
153.3
153.4
153.5
153.6
153.7
153.8
153.9
154.x
This quick reference contains many of the more frequently used codes; however, the
ultimate responsibility for correct coding lies with the provider of services.
152.0
152.1
152.2
152.3
152.8
152.9
159.x
159.0
Malignant neoplasm of small intestine,
including duodenum
Duodenum
Jejunum
Ileum
Meckel’s diverticulum
Other specified sites of small intestine
Small intestine, unspecified
Malignant neoplasm of other and
ill-defined sites within the digestive organs
and peritoneum
Intestinal tract, part unspecified
Kaposi’s Sarcoma
176.x
176.0
176.1
176.2
176.3
176.4
176.5
176.8
176.9
Kaposi’s sarcoma
Skin
Soft tissue
Palate
Gastrointestinal sites
Lung
Lymph nodes
Other specified sites
Unspecified
Janssen Biotech, Inc.
Kidney & Other Urinary Organs
189.x
189.0
189.1
189.2
189.3
189.4
189.8
189.9
Malignant neoplasm of kidney and other
and unspecified urinary organs
Kidney, except pelvis
Renal pelvis
Ureter
Urethra
Paraurethral glands
Other specified sites of urinary organs
Urinary organ site unspecified
Leukemia
The following fifth digit classification is for use
with categories 204-208:
0 without mention of having achieved remission
1 in remission
2 in relapse
204.xx
204.0x
204.1x
204.2x
204.8x
204.9x
205.xx
205.0x
205.1x
205.2x
205.3x
205.8x
205.9x
206.xx
206.0x
206.1x
206.2x
206.8x
206.9x
207.xx
207.0x
207.1x
207.2x
207.8x
208.xx
208.0x
208.1x
208.2x
208.8x
208.9x
Lymphoid leukemia
Acute
Chronic
Subacute
Other lymphoid leukemia
Unspecified lymphoid leukemia
Myeloid leukemia
Acute
Chronic
Subacute
Myeloid sarcoma
Other myeloid leukemia
Unspecified myeloid leukemia
Monocytic leukemia
Acute
Chronic
Subacute
Other monocytic leukemia
Unspecified monocytic leukemia
Other specified leukemia
Acute erythremia and erythroleukemia
Chronic erythremia
Megakaryocytic leukemia
Other specified leukemia
Leukemia of unspecified cell type
Acute
Chronic
Subacute
Other leukemia of unspecified cell type
Unspecified leukemia
Lip
140.x
140.0
140.1
140.3
140.4
140.5
140.6
140.8
140.9
Malignant neoplasm of lip
Upper lip, vermilion border
Lower lip, vermilion border
Upper lip, inner aspect
Lower lip, inner aspect
Lip, unspecified, inner aspect
Commissure of lip
Other sites of lip
Lip, unspecified, vermilion border
1 CMS
Transmittal 2727, Change Request 8355 dated
June 14, 2013, states that the ICD-9-CM update became
effective October 1, 2013. The Federal Register, Volume
9, Number 149, dated August 4, 2014, rules that ICD-9
codes can only be used until September 30, 2015.
Oncology
2015
Effective October 1, 20141
ICD-9
QUICK REFERENCE TO 2015 ICD-9-CM DIAGNOSIS CODES FOR COMMON CANCERS
Liver
155.x
155.0
155.1
155.2
Prostate
Malignant neoplasm of liver and
intrahepatic bile ducts
Liver, primary
Intrahepatic bile ducts
Liver, not specified as primary or secondary
Lung
162.x
162.0
162.2
162.3
162.4
162.5
162.8
162.9
Malignant neoplasm of trachea, bronchus,
and lung
Trachea
Main bronchus
Upper lobe, bronchus or lung
Middle lobe, bronchus or lung
Lower lobe, bronchus or lung
Other parts of bronchus or lung
Bronchus and lung, unspecified
Lymphoma
The following fifth-digit subclassification is for
use with categories 200-202:
0 unspecified site, extranodal and solid organ sites
1 lymph nodes of head, face, and neck
2 intrathoracic lymph nodes
3 intra-abdominal lymph nodes
4 lymph nodes of axilla and upper limb
5 lymph nodes of inguinal region and lower limb
6 intrapelvic lymph nodes
7 spleen
8 lymph nodes of multiple sites
200.xx
200.0x
200.1x
200.2x
200. 8x
201.xx
201.0x
201.1x
201.2x
201.4x
201.5x
201.6x
201.7x
201.9x
202.xx
202.0x
202.1x
202.2x
202.3x
203.00
203.01
203.02
Lymphosarcoma and reticulosarcoma
Reticulosarcoma
Lymphosarcoma
Burkitt’s tumor or lymphoma
Other named variants
Hodgkin’s disease
Hodgkin’s paragranuloma
Hodgkin’s granuloma
Hodgkin’s sarcoma
Lymphocytic-histiocytic predominance
Nodular sclerosis
Mixed cellularity
Lymphocytic depletion
Hodgkin’s disease, unspecified
Other malignant neoplasms of lymphoid
and histiocytic tissue
Nodular lymphoma
Mycosis fungoides
Sézary’s disease
Malignant histiocytosis
Multiple myeloma, without mention of
having achieved remission
Multiple myeloma in remission
Multiple myeloma in relapse
Ovary and Oviduct
183.x
183.0
183.2
183.3
183.4
183.5
183.8
183.9
Malignant neoplasm of ovary and other
uterine adnexa
Ovary
Fallopian tube
Broad ligament
Parametrium
Round ligament
Other specified sites of uterine adnexa
Uterine adnexa, unspecified
Pancreas
157.x
157.0
157.1
157.2
157.3
157.4
157.8
157.9
Malignant neoplasm of pancreas
Head of pancreas
Body of pancreas
Tail of pancreas
Pancreatic duct
Islets of Langerhans
Other specified sites of pancreas
Pancreas, part unspecified
Peritoneum
158.x
158.0
158.8
158.9
Malignant neoplasm of retroperitoneum
and peritoneum
Retroperitoneum
Specified parts of peritoneum
Peritoneum, unspecified
185
Malignant neoplasm of prostate
Skin
172.x
172.0
172.1
172.2
172.3
172.4
172.5
172.6
172.7
172.8
172.9
173.x
173.0
173.1
173.2
173.3
173.4
173.5
173.6
173.7
173.8
173.9
Malignant melanoma of skin
Lip
Eyelid, including canthus
Ear and external auditory canal
Other and unspecified parts of the face
Scalp and neck
Trunk, except scrotum
Upper limb, including shoulder
Lower limb, including hip
Other specified sites of skin
Melanoma of skin, site unspecified
Other malignant neoplasm of skin
Skin of lip
Eyelid, including canthus
Skin of ear and external auditory canal
Skin of other and unspecified parts of face
Scalp and skin of neck
Skin of trunk, except scrotum
Skin of upper limb, including shoulder
Skin of lower limb, including hip
Other specified sites of skin
Skin, site unspecified
Stomach
151.x
151.0
151.1
151.2
151.3
151.4
151.5
151.6
151.8
151.9
Malignant neoplasm of stomach
Cardia
Pylorus
Pyloric antrum
Fundus of stomach
Body of stomach
Lesser curvature, unspecified
Greater curvature, unspecified
Other specified sites of stomach
Stomach, unspecified
Testis
186.x
186.0
186.9
Malignant neoplasm of testis
Undescended testis
Other and unspecified testis
Tongue
141.x
141.0
141.1
141.2
141.3
141.4
141.5
141.6
141.8
141.9
Malignant neoplasm of tongue
Base of tongue
Dorsal surface of tongue
Tip and lateral border of tongue
Ventral surface of tongue
Anterior two-thirds of tongue,
part unspecified
Junctional zone
Lingual tonsil
Other sites of tongue
Tongue, unspecified
Uterus
182.x
182.0
182.1
182.8
Malignant neoplasm of body of uterus
Corpus uteri, except isthmus
Isthmus
Other specified sites of body of uterus
Secondary Sites
197.x
197.0
197.1
197.2
197.3
197.4
197.5
197.6
197.7
197.8
198.x
198.0
198.1
198.2
198.3
198.4
Secondary malignant neoplasm of
respiratory and digestive systems
Lung
Mediastinum
Pleura
Other respiratory organs
Small intestine, including duodenum
Large intestine and rectum
Retroperitoneum and peritoneum
Liver, specified as secondary
Other digestive organs and spleen
Secondary malignant neoplasm
of other specified sites
Kidney
Other urinary organs
Skin
Brain and spinal cord
Other parts of nervous system
198.5
198.6
198.7
198.8x
198.81
198.82
198.89
238.71
238.72
238.73
238.74
238.75
238.76
238.79
Bone and bone marrow
Ovary
Adrenal gland
Other specified sites
Breast
Genital organs
Other
Essential thrombocythemia
Low grade myelodysplastic syndrome lesions
High grade myelodysplastic syndrome lesions
Myelodysplastic syndrome with 5q deletion
Myelodysplastic syndrome, unspecified
Myelofibrosis with myeloid metaplasia
Other lymphatic and hematopoietic tissues
Adjunctive Care
Anemia
284.xx
284.01
284.09
284.11
Aplastic anemia
Constitutional red blood cell aplasia
Other constitutional aplastic anemia
Antineoplastic chemotherapy induced
pancytopenia
Other and Unspecified Anemia
285.x
285.0
285.2x
285.22
285.29
285.3
Other and unspecified anemias
Sideroblastic anemia
Anemia in chronic illness
Anemia in neoplastic disease
Anemia of other chronic disease
Antineoplastic chemotherapy induced anemia
Thrombocytopenia
287.x
287.41
287.49
Purpura and other hemorrhagic conditions
Posttransfusion purpura
Other secondary thrombocytopenia
Agranulocytosis
288.xx
288.00
288.01
288.02
288.03
288.04
288.09
Diseases of white blood cells
Neutropenia, unspecified
Congenital neutropenia
Cyclic neutropenia
Drug induced neutropenia
Use additional E code to identify drug
Neutropenia due to infection
Other neutropenia
Nausea / Vomiting
787.x
787.0x
787.01
787.02
787.03
787.04
Symptoms involving digestive system
Nausea and vomiting
Nausea with vomiting
Nausea alone
Vomiting alone
Bilious emesis
Drugs, Medicinal and Biological Substances
Causing Adverse Effects in Therapeutic Use
(E930-E949)
E930.x
E930.7
E933.x
E933.1
Antibiotics
Antineoplastic antibiotics
Primarily systemic agents
Antineoplastic and immunosuppressive drugs
Supplementary Classification of Factors
Influencing Health Status and Contact with
Health Services
V58.xx
V58.11
V58.12
Encounter for other and unspecified
procedures and aftercare
Encounter for antineoplastic chemotherapy
Encounter for antineoplastic immunotherapy
PROCRITline®
Phone: 1-800-553-3851
Fax: 1-800-987-5572
Hours of Operation: Monday - Friday 8 AM to 8 PM ET
© Janssen Biotech, Inc. 2015 031580-150319